Jackie Dishner, Phoenix.
Ziyad Al-Aly, MD, director, Medical Epidemiology Middle, Washington College, St. Louis; chief of Analysis and Improvement Service, Veterans Affairs St. Louis Well being Care System.
Nature Medication: “Acute and postacute sequelae related to SARS-CoV-2 reinfection.”
The Lancet eClinical Medication: “Affect of COVID-19 vaccination on the chance of creating long-COVID and on current long-COVID signs: A scientific overview.”
The British Medical Journal: “Trajectory of lengthy covid signs after covid-19 vaccination: group based mostly cohort examine.”
Stephen J. Thomas, MD, director, Institute for International Well being and Translational Science, Upstate Medical College, Syracuse, NY.
Cell Demise & Differentiation, “Lengthy Covid: the place we stand and challenges forward.”
Scott Roberts, MD, affiliate medical director, an infection prevention, Yale New Haven Hospital, New Haven, CT.
Yale Faculty of Medication Iwasaki Lab: “Immunology of lengthy COVID.”
FDA: “Covid-19 Bivalent Vaccine Boosters.”
CDC: “Keep As much as Date with COVID-19 Vaccines Together with Boosters,” “COVID Knowledge Tracker, COVID in Your Group,” “COVID Knowledge Tracker, COVID-19 Vaccinations in america.”
The New England Journal of Medication: “A Bivalent Omicron-Containing Booster Vaccine in opposition to Covid-19.”
bioRxiv: “Improved Neutralization of Omicron BA.4/5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent BA.4/5 Vaccine.”